Comparison of Minimal Effective Dose of Sucrose for Pain Relief in Neonates After Minor Procedure
Launched by RAWALPINDI MEDICAL COLLEGE · May 31, 2024
Trial Information
Current as of February 12, 2025
Completed
Keywords
ClinConnect Summary
This study is a randomized controlled trial conducted at the Department of Pediatric Surgery, Holy Family Hospital, Rawalpindi, from March 2023 to February 2024. It aims to compare the effectiveness of two different doses of sucrose solution (0.2 ml versus 0.5 ml) for pain relief in neonates after minor procedures.
Objective:
To compare the outcome of 0.2 ml versus 0.5 ml sucrose solution for pain relief in neonates after minor procedures.
Study Design:
Randomized Controlled Trial
Study Place and Duration:
Department of Pediatric Surgery, Holy Family Hospital, Rawalpindi, March 2023 t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy term neonates admitted to the neonatal intensive care unit (NICU) and high dependency unit (HDU) at the Department of Pediatric Surgery, Holy Family Hospital, Rawalpindi.
- Exclusion Criteria:
- * Neonates with contraindications for sucrose administration, including:
- • Inability to swallow. Pharmacological muscle relaxation. Heavy sedation. Neonates who are unable to clearly view the infant's face, hindering accurate pain assessment
About Rawalpindi Medical College
Rawalpindi Medical College is a prestigious medical institution dedicated to advancing healthcare through rigorous clinical research and education. With a commitment to improving patient outcomes, the college actively sponsors clinical trials that explore innovative therapeutic approaches and enhance medical knowledge across various disciplines. Its team of experienced researchers and clinicians collaborates with national and international partners to ensure the highest standards of research integrity and ethical compliance. By fostering an environment of inquiry and excellence, Rawalpindi Medical College aims to contribute significantly to the field of medicine and the well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0